PHRRF.US Pharmather Holdings Ltd

Healthcare Biotechnology USA Stocks
0.0350 USD
Close of Nov 15, 2026
0.0322 0.1100
Market cap
USD 3.19M
P/E
-
P/B
11.58x
ROE
-225.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Aug 2026.

Is PHRRF.US undervalued?

Graham number

The Graham number of Pharmather Holdings Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pharmather Holdings Ltd fundamental analysis

No fundamental analysis for Pharmather Holdings Ltd yet.

Pharmather Holdings Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pharmather Holdings Ltd

PharmaTher Holdings Ltd., a specialty pharmaceutical and technology company, develops, acquires, and commercializes pharmaceutical products. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia, procedural sedation as well as depression, surgical and pain management. It also develops KETARX, a microneedle patch, for mental health, neuro…

Full company profile